P Malfertheiner
Overview
Explore the profile of P Malfertheiner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
537
Citations
7261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stolze T, Franke S, Haybaeck J, Moehler M, Grimminger P, Lang H, et al.
J Cancer Res Clin Oncol
. 2022 Feb;
149(3):1007-1017.
PMID: 35211781
Purpose: In a post hoc analysis of the MAGIC trial, patients with curatively resected gastric cancer (GC) and mismatch repair (MMR) deficiency (MMRd) had better median overall survival (OS) when...
2.
Haas M, Waldschmidt D, Stahl M, Reinacher-Schick A, Freiberg-Richter J, Fischer von Weikersthal L, et al.
Eur J Cancer
. 2021 Feb;
146:95-106.
PMID: 33588150
Background: Targeting the epidermal growth factor receptor pathway remains controversial in pancreatic cancer. Afatinib is an oral irreversible ErbB family blocker approved in non-small-cell lung cancer. This open-label, multicenter, randomised...
3.
Malfertheiner P, Mayerle J
MMW Fortschr Med
. 2018 Nov;
160(Suppl 3):58-63.
PMID: 30421194
No abstract available.
4.
Venerito M, Schneider C, Costanzo R, Breja R, Rohl F, Malfertheiner P
Aliment Pharmacol Ther
. 2018 Apr;
47(11):1464-1471.
PMID: 29655196
Background: Nonsteroidal anti-inflammatory drugs, low-dose aspirin, non-aspirin antiplatelet agents, anticoagulants, selective serotonin reuptake inhibitors and corticosteroids increase the risk of gastroduodenal bleeding. Aim: To determine in a retrospective cohort study...
5.
Malfertheiner P
Aliment Pharmacol Ther
. 2017 Nov;
46(11-12):1112-1113.
PMID: 29105139
No abstract available.
6.
Rosania R, Varbanova M, Wex T, Langner C, Bornschein J, Giorgio F, et al.
BMC Gastroenterol
. 2017 Jul;
17(1):84.
PMID: 28662697
Background: Gastric premalignant conditions, atrophic gastritis (AG) and intestinal metaplasia (IM) are characterized by an increase of proliferation and a reduction of apoptosis in epithelial cells. The epithelial cell kinetics...
7.
Rouzade-Dominguez M, Pezous N, David O, Tutuian R, Bruley des Varannes S, Tack J, et al.
Neurogastroenterol Motil
. 2017 Mar;
29(8).
PMID: 28337838
Background: Transient lower esophageal sphincter relaxations (TLESRs) induced by gastric distension are modulated by the metabotropic glutamate receptor 5 (mGluR5) that influences the vagal reflex loop. We therefore aimed to...
8.
von Arnim U, Rohl F, Miehlke S, Jechorek D, Reinhold D, Wex T, et al.
Aliment Pharmacol Ther
. 2017 Feb;
45(6):861.
PMID: 28211624
No abstract available.
9.
von Arnim U, Miehlke S, Madisch A, Vieth M, Straumann A, Malfertheiner P
Laryngorhinootologie
. 2017 Feb;
96(1):11-21.
PMID: 28192821
Eosinophilic esophagitis (EoE) is a clinicopathological condition of the esophagus that has become increasingly recognised over the last decade. EoE represents a chronic immune-mediated inflammatory disease of the esophagus. In...
10.
von Arnim U, Rohl F, Miehlke S, Jechorek D, Reinhold D, Wex T, et al.
Aliment Pharmacol Ther
. 2016 Nov;
45(3):417-426.
PMID: 27896821
Background: Eosinophilic oesophagitis (EoE) and gastro-oesophageal reflux disease (GERD) present with overlapping symptomatology and it is challenging to distinguish EoE from GERD clinically before endoscopy. Aim: To investigate the prognostic...